Bisphosphonates for prevention of hip fractures effective but costly Clinical study 11 April 2015 Pages: 7 - 7
Cost per cure similar for new vs older regimens for HCV GT1 Clinical study 11 April 2015 Pages: 9 - 9
Costs same for RA regardless of baseline disease activity Clinical study 11 April 2015 Pages: 11 - 11
Higher-value diabetes interventions save costs, gain QALYs Clinical study 11 April 2015 Pages: 13 - 13
Hypnosedatives for geriatric insomnia costly due to risk of falls Clinical study 11 April 2015 Pages: 15 - 15
Ingenol mebutate gel cost effective for AK treatment in Scotland Clinical study 11 April 2015 Pages: 16 - 16
Investing in TB control results in economic gains across border Clinical study 11 April 2015 Pages: 17 - 17
Is surveillance imaging during DLBCL follow-up worthwhile? Clinical study 11 April 2015 Pages: 19 - 19
Isoniazid highly cost effective for high-risk women in India Clinical study 11 April 2015 Pages: 20 - 20
Ledipasvir/sofosbuvir improves QOL in patients with liver fibrosis Clinical study 11 April 2015 Pages: 21 - 21
New HCV treatments: substantial benefits at reasonable cost Clinical study 11 April 2015 Pages: 22 - 22
Oncotype DX testing directs therapy and saves costs in Ireland Meeting report 11 April 2015 Pages: 23 - 23
Oocyte cryopreservation cost effective for deferred pregnancy Clinical study 11 April 2015 Pages: 24 - 24
Rabies post-exposure prophylaxis: assessing costs and benefits Clinical study 11 April 2015 Pages: 26 - 26
Risks and benefits of discontinuing statins in advanced illness Clinical study 11 April 2015 Pages: 27 - 27
Sofosbuvir-based regimens good value for HCV genotype 2/3 Clinical study 11 April 2015 Pages: 29 - 29
The fine line of early ART eligibility and its consequences Clinical study 11 April 2015 Pages: 31 - 31